Awarded contract

Enzyme Replacement Therapy Medicines

Details

Buyer: NHS National Services Scotland
Supplier(s): Takeda UK Limited
Value: GBP 6,079,596
Topic: Pharmaceutical products
Published: 2 July 2024
Source: uk:find_a_tender

Tender description

Supply of Enzyme Replacement Therapy Medicines (e-g) to NHS Scotland: - NP92624(e) Velaglucerase alfa 400units powder for solution for infusion vials 1 vial (VPRIV®) - NP92624(f) Idursulfase 6mg/3ml solution for infusion vials 1 vial (Elaprase®) - NP92624(g) Agalsidase alfa 3.5mg/3.5ml solution for infusion vials 1 vial (Replagal®) Lot 1: The Framework Agreement is for the supply of Enzyme Replacement Therapy Medicines (e-g: VPRIV®/ Elaprase®/ Replagal®) to NHS Scotland. The Authority has awarded this framework as a Single supplier framework agreement to one (1) Framework Participant.

Timeline

Completed: Award published2 July 2024
Current notice
Completed: Award date19 July 2024

About the buyer

NHS National Services Scotland is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

33600000 · Pharmaceutical products

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@nhs-national-services-scotland.gov
Commercial Director	+44 •••• ••••••	••••••••@nhs-national-services-scotland.gov
Procurement Manager	+44 •••• ••••••	••••••••@nhs-national-services-scotland.gov
Category Lead	+44 •••• ••••••	••••••••@nhs-national-services-scotland.gov
Senior Buyer	+44 •••• ••••••	••••••••@nhs-national-services-scotland.gov
Contracts Manager	+44 •••• ••••••	••••••••@nhs-national-services-scotland.gov